Home Applications 205060 Application 205060
Type NDA
Sponsor ASTRAZENECA PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 EPANOVA OMEGA-3-CARBOXYLIC ACIDS CAPSULE;ORAL 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205060-001 EPANOVA OMEGA-3-CARBOXYLIC ACIDS 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS CAPSULE / ORAL RLD 2014-05-05
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N205060-001 7960370 2026-12-20 Drug product 2014-06-03 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 N205060-001 9050309 2033-01-04 Drug substance 2015-07-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N205060-001 EPANOVA 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS CAPSULE / ORAL RLD 2014-05-05 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N205060-001 EPANOVA 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS CAPSULE / ORAL RLD 2014-05-05 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N205060-001 EPANOVA 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS CAPSULE / ORAL RLD 2014-05-05 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N205060-001 EPANOVA 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS CAPSULE / ORAL RLD 2014-05-05 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N205060-001 EPANOVA 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS CAPSULE / ORAL RLD 2014-05-05 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 8 · 309 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N205060-001 7960370 2026-12-20 Drug product 2014-06-03 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N205060-001 9050309 2033-01-04 Drug substance 2015-07-07 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N205060-001 7960370 2026-12-20 Drug product 2014-06-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205060-001 9050309 2033-01-04 Drug substance 2015-07-07 c2088c7a36db…2026-09-14 22:38:34 2026-08 N205060-001 7960370 2026-12-20 Drug product 2014-06-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205060-001 9050309 2033-01-04 Drug substance 2015-07-07 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205060-001 7960370 2026-12-20 Drug product 2014-06-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205060-001 9050309 2033-01-04 Drug substance 2015-07-07 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205060-001 7960370 2026-12-20 Drug product 2014-06-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205060-001 9050309 2033-01-04 Drug substance 2015-07-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205060-001 8383678 2025-02-07 U-1511 Drug product 2014-06-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205060-001 9012501 2025-02-07 U-1511 Drug product 2015-05-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205060-001 9132112 2025-02-07 U-1511 Drug product 2015-09-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205060-001 7960370 2026-12-20 Drug product 2014-06-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205060-001 9050309 2033-01-04 Drug substance 2015-07-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205060-001 8383678 2025-02-07 U-1511 Drug product 2014-06-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205060-001 9012501 2025-02-07 U-1511 Drug product 2015-05-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205060-001 9132112 2025-02-07 U-1511 Drug product 2015-09-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205060-001 7960370 2026-12-20 Drug product 2014-06-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205060-001 9050309 2033-01-04 Drug substance 2015-07-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205060-001 8383678 2025-02-07 U-1511 Drug product 2014-06-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205060-001 9012501 2025-02-07 U-1511 Drug product 2015-05-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205060-001 9132112 2025-02-07 U-1511 Drug product 2015-09-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205060-001 7960370 2026-12-20 Drug product 2014-06-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205060-001 10117844 2033-01-04 U-2447 2018-12-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205060-001 9050308 2033-01-04 U-1511 2015-07-07 fd3edfee7708…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2019-12-13 00:20 UTC 2019-12 N205060-001 NCE 2019-05-05 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N205060-001 NCE 2019-05-05 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N205060-001 NCE 2019-05-05 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N205060-001 NCE 2019-05-05 ea99ee380514…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 47548 SUPPL 2017-03-14 47521 SUPPL 2017-03-10 46928 SUPPL 2017-01-23 45608 SUPPL 2016-10-12 45524 SUPPL 2016-10-12 43483 ORIG 2016-03-28 32624 ORIG 2014-05-06 19618 ORIG 2014-05-06